[Federal Register Volume 84, Number 44 (Wednesday, March 6, 2019)]
[Notices]
[Pages 8100-8101]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04011]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-19-19MM; Docket No. CDC-2019-0006]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Study on Disparities in Distress
Screening among Lung and Ovarian Cancer Survivors. The goal of this
study is to understand the processes, facilitators, and barriers
related to implementing distress screening in 50 healthcare facilities.
DATES: CDC must receive written comments on or before May 6, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0006 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Study on Disparities in Distress Screening Among Lung and Ovarian
Cancer--New--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC)
Background and Brief Description
Within the cancer treatment community, interest in the psychosocial
impacts of cancer diagnosis and treatment is increasing. These
psychosocial impacts are wide ranging and include not only anxiety
related to the illness and treatment side effects such as pain, fatigue
and cognition, but also stress related to nonmedical issues such as
family relationships, financial hardship, social stressors (e.g.
transportation), and stigmatization. There is growing evidence that
addressing the psychosocial stresses of cancer survivors increases both
their longevity and quality of life.
The 2016 Institute of Medicine (currently, National Academies of
Sciences, Engineering, and Medicine) ovarian cancer report, funded by
CDC, calls for increased study of the psychosocial needs of ovarian
cancer survivors, recognizing the high rates of depression, anxiety,
and distress. Up to 60% of lung cancer survivors also experience high
levels of distress. Both ovarian and lung cancer patients have
relatively low 5-year survival rates (45% and 17%, respectively).
Therefore, CDC believes that it is imperative to develop a greater
understanding about the types of psychosocial services they receive
during their course of treatment and follow-up care.
CDC proposes a new information collection to examine the extent to
which disparities exist in distress screening and follow-up among
cancer treatment facilities and programs across the country. The study
will include 50 healthcare facilities. From these facilities, we will
request electronic health records (EHR) of 2,000 lung and ovarian
cancer survivors. Data elements collected will include patient
demographic information, cancer diagnosis and treatment, experience
with distress screening and follow-up care, and medical service
utilization. Patient names, addresses, birth dates and Social Security
Numbers will not be collected.
Staff from twelve of the 50 participating healthcare facilities
will be invited to participate in an interview and focus group to
provide contextual understanding about facilitators and barriers to
distress screening and follow-up processes. This is a one-time data
collection. Results of this study will provide CDC's National
Comprehensive Cancer Control Program (NCCCP) with information to assist
with the development of information, resources, technical assistance,
and future evidence-based interventions to improve the quality of life
of lung and ovarian cancer survivors. Summative findings will be used
to evaluate the need to help with policy, systems, or environmental
changes that may enhance the landscape of quality of life services for
cancer survivors in communities at large. OMB approval is
[[Page 8101]]
requested for one year. The total estimated annualized burden hours are
512.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Quantitative:
Healthcare Professionals Survey.......... 50 1 20/60 17
(POC).
IT Staff.................. EMR data........ 50 1 7.5 375
Qualitative:
Healthcare Professionals.. Key Informant 12 1 1 12
Interview.
Focus Groups.... 72 1 1.5 108
---------------------------------------------------------------
Total................. ................ .............. .............. .............. 512
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-04011 Filed 3-5-19; 8:45 am]
BILLING CODE 4163-18-P